Walter J. Storkus

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Cell Biology, Microbiology Biology
Google:
"Walter Storkus"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pontrelli P, Gigante M, Spadaccino F, et al. (2021) CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation. International Journal of Molecular Sciences. 22
Amouzegar A, Chelvanambi M, Filderman JN, et al. (2021) STING Agonists as Cancer Therapeutics. Cancers. 13
Filderman JN, Appleman M, Chelvanambi M, et al. (2021) STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development. Frontiers in Immunology. 12: 690105
Dasgupta S, Ghosh T, Dhar J, et al. (2021) RGS5-TGFβ-Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth. Cell Death and Differentiation
Salem D, Chelvanambi M, Storkus WJ, et al. (2021) Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation. Frontiers in Immunology. 12: 629519
Lejeune FJ, Storkus WJ, Riley PA. (2021) Thirty years of therapeutic innovation in melanoma research. Melanoma Research
Chelvanambi M, Fecek RJ, Taylor JL, et al. (2021) STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Journal For Immunotherapy of Cancer. 9
Hao X, Falo Iii LD, Chen G, et al. (2021) Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors. Journal For Immunotherapy of Cancer. 9
Close DA, Kirkwood JM, Fecek RJ, et al. (2020) Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines. Slas Discovery : Advancing Life Sciences R & D. 2472555220970917
Maurer DM, Adamik J, Santos PM, et al. (2020) Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma. Cancer Immunology Research
See more...